The Indian Council of Medical Research (ICMR) and Panacea Biotec have initiated the first-ever phase three clinical trial for developing a dengue vaccine in India, the Union Health Ministry said on......
Dengue has become a major public health concern in India with 289,235 cases reported last year. This year there were 19,447 cases of dengue which resulted in 19 deaths till April 2024. Kindly......
The government may look at areas around Thonnakkal, in Thiruvananthapuram district, for the facility. If successful, this would be one of the few sites of Sputnik V owned by Russian firms......
'Its efficacy is 97.6 per cent.' Morepen India Chairman and Managing Director Sushil Suri in an interview with Uddalok Bhattacharya says the Sputnik V vaccine it is manufacturing in India......
Officers sitting over untapped potential to make COVID-19 vaccines need to be charged with 'manslaughter' as it is leading to so many deaths, the Delhi high court said on Wednesday, observing that......
Mumbai outpaced Bangalore, with a margin of about Rs 200 crore (Rs 2 billion), to become India's top biotech city in terms of revenue while Bangalore-based bio pharmaceuticals major Biocon clocked......
Only six of the top 25 drug companies, which include Dr Reddy's Lab, Sun Pharma and Zydus Cadila, could post better net profit in the December quarter in comparison to the corresponding previous......
The World Health Organization has given five more months to the Drugs Controller General of India to upgrade its performance to international standards. The extension of the current deadline of......
The World Health Organization has not approved any new vaccine from India this year as the Indian regulatory system, which gives manufacturing licences for domestic vaccines, has failed to meet its......
London-based SPG Media, publishers of the annual World Pharmaceutical Frontiers survey, has included five Indians among the top 40 influential people in the global pharmaceutical industry in 2008.......